Skip to content

Homeopathic treatment of acute paronychia

A double-blind, randomized, placebo-controlled trial of individualized Dioscorea villosa for the treatment of acute paronychia among adults - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101338
Enrollment
108
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L030- Cellulitis and acute lymphangitisof finger and toe

Interventions

Intervention1: Dioscorea villosa and concomitant care: Intervention is planned as administering Dioscorea villosa 30CH 4 doses a day for 2 days. Dioscorea villosa 200CH will be administered if symptom
twice daily for one day, followed by another dose the next day. Dioscorea villosa 1000CH single dose will be administered. Each dose will consist of 4 cane sugar globules. 40 moistened with Dioscorea

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 65 years. 2. Patients suffering from Acute paronychia [ICD-11 code: EE13.0] 3. Any one of the following symptoms of sufficient magnitude should be present as listed below: a. Pain is sharp and agonizing when pricking is first felt. b. Nails are brittle. c. Pain spread, especially from the abdomen to distant parts. d. Any symptoms better by stretching out and moving about.

Exclusion criteria

Exclusion criteria: 1.Patient is denying consent to participate. 2.Patients with paronychia requiring surgical intervention at baseline. 3.Patients with a history of contact dermatitis from steroids, onychomycosis, psoriasis, lichen planus, or recent steroid/antibiotic treatment for paronychia. 4.Patients agreed not to use any other topical products. 5.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 6.Pregnant and puerperal women, lactating mothers. 7.Vulnerable population unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, institutionalized subjects, mentally incompetent people. 8.Habit of tobacco chewing, smoking, and other forms (s) of substance abuse and/or dependence. 9.Self-reported immune-compromised state. 10.Already undergoing homeopathic treatment for chronic disease for the last 2 weeks.

Design outcomes

Primary

MeasureTime frame
Numerical Rating Scale (NRS)Timepoint: Baseline, 1st, 2nd, 5th, 7th, 14th and 21st day.

Secondary

MeasureTime frame
NAIL-QTimepoint: Baseline, 7th day, 14th and 21st day.

Countries

India

Contacts

Public ContactShreyasi Das

D N De Homoeopathic Medical College and Hospital

priyankasen072@gmail.com08259024415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026